Table 3.

Body weight of the studied women [kg].

Treatment	Baseline	After 10 Treatments vs. Baseline	p	After 6 Months vs. Baseline	p
U	63.3 (60–70)	62.9 (58.8–68.7)	0.01	62.5 (58–72.6)	0.1
RF	69.75 (64–79.2)	67.6 (63.5–78)	0.0035	67.75 (63.8–77)	0.04
RF/U	68 (64.5–82.8)	67.75 (64.3–81.5)	0.009	68.1 (62.5–80)	0.3

Abbreviations: Destination U, group treated with ultrasound; RF, group treated using radiofrequency device. All continuous variables are expressed as a median and interquartile range [Q1–Q3] as not normally distributed. The Shapiro–Wilk test was used to check if a continuous variable follows a normal distribution. Differences were statistically significant at p < 0.05.